D-1613-2014 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- October 8, 2014
- Initiation Date
- May 5, 2014
- Termination Date
- April 1, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 136 boxes
Product Description
Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.
Reason for Recall
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
Distribution Pattern
To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC
Code Information
All lots